Boonton, NJ, United States of America

Mikhail Laksin

This inventor holds 28 USPTO granted patents and 3 published patent applications, plus 11 CIPO patents and 9 EPO patents, primarily in Energy Curable Inks. Top assignees: Sun Chemical Corporation, Ideon LLC, Pepsico, Inc.. Active years: 2001-2021.

USPTO Granted Patents = 28 

% Patents Active = 78.6

 

 

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 145(Granted Patents)


Location History:

  • Scotch Plains, NJ (US) (2001 - 2007)
  • Boonton, NJ (US) (2009 - 2021)
  • Booton, NJ (US) (2021)

Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Energy Curable Inks
Custom Graphic Film
Radiation Curable Compositions
Electron Beam Curing
Water Based Inks
Lithographic Inks
Flexographic Printing
Low VOC Inks
Hybrid Systems
Printed Packaging
Liquid Radiation Curable Inks
Grafted Pigments
28 patents (USPTO):Explore Patents

Title: Inventor Mikhail Laksin: Pioneering Innovations in Boonton

Introduction: Mikhail Laksin is a renowned inventor based in Boonton, New Jersey, known for his groundbreaking contributions to various technological fields.

Latest Patents: Mikhail Laksin holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse expertise and innovative mindset.

Career Highlights: With a career spanning over two decades, Mikhail Laksin has worked with leading research institutions and companies to develop cutting-edge solutions that have significantly impacted the industry.

Collaborations: Throughout his career, Mikhail Laksin has collaborated with top engineers, scientists, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Mikhail Laksin's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…